Double-blind, randomized, placebo-controlled study of three-month treatment with the combination of ofloxacin and roxithromycin in recent-onset reactive arthritis

@article{Kuuliala2013DoubleblindRP,
  title={Double-blind, randomized, placebo-controlled study of three-month treatment with the combination of ofloxacin and roxithromycin in recent-onset reactive arthritis},
  author={Antti Kuuliala and Heikki Julkunen and Leena H Paimela and Ritva L Peltomaa and Hannu Kautiainen and Heikki Repo and Marjatta Leirisalo-Repo},
  journal={Rheumatology International},
  year={2013},
  volume={33},
  pages={2723-2729}
}
In a randomized, double-blind, placebo-controlled trial, 56 patients with recent-onset ReA [enteroarthritis, n = 47 (84 %); uroarthritis, n = 9 (16 %)] were randomly assigned to receive 200 mg ofloxacin and 150 mg roxithromycin twice daily (Combi, n = 26) or placebo (n = 30) for 3 months. Patients were assessed at entry, at 2 weeks, and at 1, 2, 3, 4, 5… CONTINUE READING